Stocks  /  NASDAQ  /  Liminatus Pharma Inc.

Liminatus Pharma Inc.

Industry:   Health Care – Biotechnology

Stock Symbol:   LIMNNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Liminatus Pharma Inc. is a pre-clinical-stage biopharmaceutical company developing novel cancer therapies. Due to the industry and stage of development, the company is required to use animal testing for pre-clinical studies (toxicology, safety, and efficacy) of its new drug candidates, such as its anti-CD47 monoclonal antibody (IBA101), to meet regulatory requirements before advancing to human clinical trials.

Company Description

Scroll to Top